Loratadine Dosage Information

Overview

Loratadine is available over the counter in the United States in several formulations and strengths. Product labels provide specific dosing information based on age, weight, and formulation. This page provides an informational overview of standard dosing patterns typically found on loratadine product labels for over-the-counter use.

It is important to note that this information is for educational purposes and describes what product labels commonly indicate. Individual dosing needs may vary based on specific health conditions, kidney function, liver function, and other factors. People with questions about appropriate dosing should consult product labeling or speak with a healthcare provider or pharmacist.

Standard Adult Dosing

Product labels for over-the-counter loratadine typically indicate the following dosing information for adults and children 6 years of age and older.

Standard dose:

10 mg taken once daily
This is the standard dose for most adults and children 6 years and older

Timing:

Can be taken at any time of day
Taking at the same time each day helps maintain consistent levels
Can be taken in the morning or evening based on personal preference
Because loratadine is minimally sedating, timing is flexible

With or without food:

Loratadine can be taken with or without food
Food does not significantly affect absorption or effectiveness

The once-daily dosing schedule is based on loratadine’s approximately 24-hour duration of action.

Maximum Daily Dose

Product labels typically indicate that the maximum dose of loratadine for adults and children 6 years and older is 10 mg in a 24-hour period.

Taking more than the maximum indicated dose does not provide significantly better symptom relief but may increase the risk of side effects.

Dosing for Children

Loratadine is available in formulations specifically designed for children, including liquid solutions and chewable tablets.

Children Ages 6 Years and Older

Product labels typically indicate:

10 mg once daily
Available in standard tablets, chewable tablets, or liquid formulations
Same dose as adults

Children Ages 2 to Under 6 Years

Product labels for children’s loratadine formulations typically indicate:

5 mg once daily
Commonly given as chewable tablets or liquid formulation
Liquid formulation: 5 mL (one teaspoonful) once daily for products containing 1 mg per mL

Children Under 2 Years

Loratadine is not indicated for use in children under 2 years of age according to standard over-the-counter product labeling. Use in this age group should only occur under healthcare provider direction.

Important Considerations for Children

Always use the measuring device that comes with liquid formulations
Do not use household spoons, as they do not provide accurate measurements
Follow age-specific dosing on product labels carefully
Children’s liquid formulations typically contain 1 mg per mL (5 mg per 5 mL)
Some chewable tablets contain phenylalanine and should be avoided in children with phenylketonuria (PKU)

Dosing for Special Populations

Certain groups may require modified dosing based on individual health factors.

People with Kidney Disease

Loratadine is eliminated primarily through the kidneys. People with reduced kidney function may require modified dosing to avoid accumulation of the medication.

Common modifications for kidney impairment:

Mild kidney impairment: Dosing may not need adjustment
Moderate to severe kidney impairment: Product labels may indicate dosing every other day or lower doses
Specific recommendations vary based on the degree of kidney impairment

Healthcare provider guidance is important for people with known kidney disease.

People with Liver Disease

Loratadine is extensively metabolized in the liver to its active metabolite, desloratadine. People with liver disease may process the medication differently.

Common modifications for liver impairment:

Significant liver disease may warrant dosing every other day
Healthcare provider guidance is recommended
Monitoring for increased side effects may be appropriate

Elderly Individuals

Older adults generally tolerate loratadine well due to its low sedation profile. However, age-related changes in kidney and liver function may affect how the medication is processed.

Considerations for elderly individuals:

May have reduced kidney function requiring dosage adjustment
May have reduced liver function affecting metabolism
Generally start with standard dosing but monitor for effectiveness and side effects
Lower risk of problematic sedation compared to other antihistamines

Available Formulations and Strengths

Loratadine is available in multiple forms to accommodate different preferences and age groups.

Tablets

10 mg tablets (standard adult and child 6+ dose)
Standard tablets that are swallowed whole

Orally Disintegrating Tablets

Dissolve on the tongue without water
Typically available in 10 mg strength
Convenient for people who have difficulty swallowing tablets
Some formulations contain phenylalanine (important for people with PKU)

Chewable Tablets

Designed primarily for children but can be used by adults
Typically available in 5 mg and 10 mg strengths
Fruit-flavored varieties are common
Some formulations contain phenylalanine (important for people with PKU)

Liquid-Filled Capsules

Soft gelatin capsules containing liquid loratadine
Typically 10 mg strength

Oral Solution (Liquid)

Typically 1 mg per mL (5 mg per 5 mL or teaspoonful)
Used primarily for children
Comes with measuring device (oral syringe or dosing cup)
Available in various flavors

Syrup

Similar to oral solution
May contain different inactive ingredients such as sweeteners
Also typically 1 mg per mL concentration

Combination Products

Loratadine is also available in combination with other active ingredients, most commonly decongestants such as pseudoephedrine (marketed as Claritin-D and generic equivalents).

Important considerations for combination products:

Contain multiple active ingredients with different dosing schedules
Typically taken twice daily (12-hour formulations) or once daily (24-hour formulations)
Have different safety considerations than loratadine alone
Decongestant component may cause increased blood pressure, nervousness, or sleep difficulties
Should not be used alongside other products containing the same ingredients
May require checking with a pharmacist before use if taking other medications

Always read labels carefully to understand what active ingredients are present in any medication.

Missed Dose

If a dose of loratadine is missed, product labels typically suggest the following:

Take the missed dose as soon as remembered
If it is close to the time for the next scheduled dose, skip the missed dose
Do not take two doses at the same time to make up for a missed dose
Resume the regular dosing schedule

Allergy symptoms may return if a dose is missed, but symptom relief typically resumes within 1 to 3 hours after taking the next dose.

Phenylketonuria (PKU) Considerations

Some loratadine formulations contain phenylalanine, an amino acid that must be restricted in people with phenylketonuria (PKU).

Products that may contain phenylalanine:

Orally disintegrating tablets
Some chewable tablets

Important for people with PKU:

Check product labels carefully for phenylalanine content
The amount of phenylalanine per dose is typically listed on the label
Standard tablets and liquid formulations typically do not contain phenylalanine
Consult with a healthcare provider if uncertain about which formulation is appropriate

Important Safety Reminders

Several safety considerations apply to loratadine dosing.

Do Not Exceed Indicated Doses

Taking more loratadine than indicated on product labels does not provide significantly better symptom relief but may increase the risk of side effects. While loratadine has a wide safety margin, exceeding recommended doses is not advisable.

Avoid Duplicate Dosing

Many over-the-counter allergy, cold, and sinus medications contain antihistamines. Using multiple products simultaneously can result in taking more antihistamine than intended. Always check product labels for active ingredients.

Minimal Drowsiness Risk

Loratadine is one of the least sedating antihistamines available, with drowsiness rates comparable to placebo. However, individual responses vary, and people should still determine how loratadine affects them before driving or operating machinery, particularly when first starting the medication.

Alcohol Interaction

While loratadine is less likely to interact with alcohol compared to other antihistamines, combining any antihistamine with alcohol is generally not recommended, as alcohol itself can cause drowsiness and impaired coordination.

Long-Term Use

Loratadine can be used daily for extended periods for chronic allergy management. People using loratadine long-term should have periodic check-ins with a healthcare provider, particularly if they have kidney disease, liver disease, or other health conditions.

When Standard Dosing May Not Be Appropriate

Several situations may require healthcare provider guidance regarding loratadine dosing:

Kidney disease or reduced kidney function
Liver disease or reduced liver function
Pregnancy or breastfeeding
Use in children under 2 years of age
Phenylketonuria (PKU) when considering certain formulations
Concurrent use of medications that affect liver enzymes
History of unusual reactions to antihistamines

In these situations, consulting a healthcare provider or pharmacist before using loratadine is advisable.

When to Seek Medical Guidance

Medical advice should be sought in certain situations related to loratadine dosing and use.

Contact a healthcare provider if:

Uncertain about appropriate dosing for a specific situation
Symptoms do not improve with standard dosing after several days
Considering use in children under 2 years of age
Kidney or liver disease is present
Taking multiple medications and uncertain about interactions
Experiencing unusual side effects even at standard doses
Questions arise about long-term use

Seek emergency care if:

Accidental overdose occurs, particularly in children
Severe dizziness or fainting develops
Difficulty breathing or signs of allergic reaction appear
Rapid or irregular heartbeat occurs
Unusual or severe symptoms develop

Sources

This information is based on data from the following authoritative sources:

U.S. Food and Drug Administration (FDA). Loratadine Drug Label Information.
MedlinePlus, U.S. National Library of Medicine. Loratadine.
FDA Consumer Health Information. Use of OTC Antihistamines in Children.
National Institutes of Health (NIH). Loratadine Dosing Guidelines.
American Academy of Pediatrics. Antihistamine Use in Pediatric Patients.
Clinical Pharmacology. Loratadine Dosing in Renal and Hepatic Impairment.